Equity Research, Broker Reports, and media content on Allergy Therapeutics plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Allergy Therapeutics plc

Company Profile

  • Personnel
  • Manuel Llobet , CEO
  • Nicolas Wykeman, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics plc. We currently have 241 research reports from 10 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 7.00/21.5p
  • Daily Volume: N/A
  • Daily Liquidity: (0.03%)
  • # Shares: 637.3m
  • Market Cap: £105.6m
  • Latest PE (hist): 23.36
  • Div Yield:
Date Source Announcement
20Nov20 13:51 RNS Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 RNS Director/PDMR Shareholding
10Nov20 07:05 RNS Annual Report & Accounts and AGM Notification
26Oct20 07:00 RNS Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 RNS Holding(s) in Company
09Oct20 07:00 RNS Director Dealings and Issue of Equity
23Sep20 07:00 RNS Preliminary Results
  • Frequency of research reports

     

  • Research reports on

    Allergy Therapeutics plc

  • Providers covering

    Allergy Therapeutics plc